People with type 2 diabetes are advised to limit their junk food intake and instead focus on maintaining a healthy diet that is rich in nutrients
While dose adjustment is not generally required for mild to moderate renal or hepatic impairment, tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is not recommended in these populations
Discover 15 Neumi Skin Care and skin care ideas | skin, motivational quotes, technology and more Skip to content Explore When autocomplete results are available use up and down arrows to review and enter to select
doi: 10.3390/cells7070084 129 KomatsuS-iWatanabeHOkaTTsugeHNiiHKatoN
References: FDA Mounjaro Approval, FDA Zepbound Approval Indications and Contraindications Approved Uses Type 2 diabetes mellitus (as an adjunct to diet and exercise) Chronic weight management in adults with BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity Contraindications Personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Hypersensitivity to tirzepatide or any component of the formulation Note: Tirzepatide is not indicated for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis
APTT, activated partial thromboplastin time